Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to assess the patient self-medication practices during and after cancer in France, using an online questionnaire
Patients will be contacted by email from patient's associations. Patients will be informed of the objectives of the study and will be free to answer or not to the online questionnaire.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Self-medication | declaration of a practice of self-medication | day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| Class of products used in self-medication | non-prescription medicine, herbal medicine, aromatherapy, homeopathy, and food supplements | day 1 |
| Indication for self-medication | For treatment of side-effects, improvements in anti-cancer effects |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients contacted by cancer patient's association
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU Clermont-Ferrand | Clermont-Ferrand | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| day 1 |
| Origin of self-medication products | pharmacy, market, internet, other | day 1 |
| Perception of adverse effects and drug-drug interaction related to self medication | yes / no | day 1 |
| QLQ-C30 questionnaire | Global health status Functional scales Physical functioning Role functioning Emotional functioning Cognitive functioning Social functioning Fatigue Nausea and vomiting Pain Dyspnoea Insomnia Appetite loss Constipation Diarrhoea Financial difficulties | day 1 |